sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Pharmaceuticals & Biotech

Cannabinoids MarketSize, Share & Industry Analysis, 2026-2034By Cannabinoid TypeBy SourceBy Product FormBy Extraction MethodBy ApplicationBy Spectrum ProfileBy Purity GradeBy Route of AdministrationBy Distribution ChannelBy Legal Status

Full title & scope — all 10 axes with their segments

Cannabinoids Market Size, Share & Industry Analysis, By Cannabinoid Type (Cannabidiol, Tetrahydrocannabinol, Cannabigerol, Cannabinol, Cannabichromene, Cannabidiolic Acid, Other Cannabinoids), By Source (Hemp-Derived, Marijuana-Derived, Synthetic, Semi-Synthetic), By Product Form (Isolate, Distillate, Crude Extract, Oils and Tinctures, Capsules and Softgels, Edibles, Topicals, Vapes and Inhalables), By Extraction Method (CO2 Extraction, Solvent Extraction, Solventless Extraction, Chemical Synthesis and Biosynthesis), By Application (Pharmaceuticals, Nutraceuticals and Dietary Supplements, Food and Beverages, Cosmetics and Personal Care, Recreational and Adult Use, Pet and Veterinary Products, Research and Others), By Spectrum Profile (Full-Spectrum, Broad-Spectrum, Isolate), By Purity Grade (Pharmaceutical Grade, Food and Nutraceutical Grade, Cosmetic Grade, Industrial and Research Grade), By Route of Administration (Oral, Topical and Transdermal, Inhalation, Oromucosal Spray, Others), By Distribution Channel (Pharmacies and Drug Stores, Licensed Dispensaries, Online and E-commerce, Specialty and Health Stores, Business-to-Business Bulk Supply), By Legal Status (Prescription, Medical Cannabis Programmes, Adult-Use Regulated, Hemp-Derived Consumer Wellness), and Regional Forecast, 2026-2034

Last Updated: Oct 28, 2026Format: PDFReport ID: CDI-248814
Analyst Support

Talk to the analyst who built the estimates, and shape the scope around your question.

Complimentary Analyst Access

Every report purchase includes direct access to the lead analyst for scoping questions on the data, at no extra cost and with no separate booking process.

Custom Data Cuts

Request a tailored breakdown by geography, segment, or competitor set beyond what's in the standard report.

Speak to an Analyst
Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Cannabinoids Market projected to reach?

USD 113.6 USD Billion by 2034, CAGR 13.59%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 40% of global revenue through 2034.

05Which segment leads the market?

Cannabidiol (CBD) is the largest line by cannabinoid type, at 55% of revenue in 2025.

06Who are the key companies profiled?

Jazz Pharmaceuticals plc, Canopy Growth Corporation, Tilray Brands, Inc., Charlotte's Web Holdings, Inc., Aurora Cannabis Inc., Curaleaf Holdings, Inc., Cresco Labs Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., Mile High Labs, Inc., Medterra CBD, cbdMD, Inc., Isodiol International Inc., Elixinol Wellness Limited, Folium Biosciences, Cannexus Group, Cannextra, Red Mesa Science & Refining, Big Sky Scientific, Avient Biosciences, Organigram Global Inc., SNDL Inc., Bausch Health Companies Inc., Neuraxpharm Group, Botanix Pharmaceuticals Limited, Zynerba Pharmaceuticals, Inc., Aphria Inc., CV Sciences, Inc., Endoca, Cronos Group Inc.. Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.